IGF system targeted therapy: Therapeutic opportunities for ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

IGF system targeted therapy: Therapeutic opportunities for ovarian cancer

Published:2017-11 Issue: Volume:60 Page:90-99
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Liefers-Visser J.A.L.,Meijering R.A.M.,Reyners A.K.L.,van der Zee A.G.J.,de Jong S.

Funder

Dutch Cancer Society, KWF

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Reference110 articles.

1. Cancer statistics, 2014;Siegel;CA Cancer J Clin,2014

2. Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial;Oza;Lancet Oncol,2015

3. Revisiting ovarian cancer preclinical models: implications for a better management of the disease;Ricci;Cancer Treat Rev,2013

4. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data;Coleman;Lancet,2011

5. Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup;Bookman;J Clin Oncol,2009

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a high-throughput kinase activity platform using nanoLC-MS/MS with DIA approach for studying the anti-cancer mechanism of Taxol in ovarian cancer;Analytica Chimica Acta;2024-08

2. Revealing the Potency of Growth Factors in Bovine Colostrum;Nutrients;2024-07-21

3. Platinum-induced upregulation of ITGA6 promotes chemoresistance and spreading in ovarian cancer;EMBO Molecular Medicine;2024-04-24

4. Prognosis and therapeutic significance of IGF-1R-related signaling pathway gene signature in glioma;Frontiers in Cell and Developmental Biology;2024-04-11

5. The IGF–PAPP-A–Stanniocalcin Axis in Serum and Ascites Associates with Prognosis in Patients with Ovarian Cancer;International Journal of Molecular Sciences;2024-02-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3